Additional file 2: Figure S2. Expression of inhibitory molecules Tim-3+ and PD-1+ on CD8+. (A) Flow cytometry results; (B) frequency of Tim-3+ cells among CD4+ and CD8+ cells in circulation of GC patients and HDs; (C) PD-1+ cells on T-cells in circulation of GC patients and HDs; (D) median percentage of PD-1+ Tim-3+ cells among CD4+ and CD8+ in GC patients and HDs; E percentage of Tim-3+ cells in different tissues; F Expression level of PD-1+ for CD8+; G PD-1+ Tim-3+ cells among T-cells
Additional file 1: Figure S1. Coexistence of CD169, CD204 and CD68 in intra-tumor (IT) of HCC and GC...
Figure S4. Tumor-derived TNF-α activates NF-κB pathway to induce PD-L1 expression on mast cells. (a)...
BackgroundGastric cancer is still one of the most lethal tumor diseases in the world. Despite some i...
Additional file 3: Figure S3. Effects of PD-1+ and Tim-3+ inhibition on IFN-Îł induction. (A) Flow c...
Figure S1. Fluorescence-activated cell sorting of CD133 in gastric cancer cell lines. CD133- cells w...
Table S1. Clinicopathological features of diffuse-type GC patients whose cancers were used to establ...
Figure S2. CXCL12-CXCR4 chemotaxis mediates mast cell migration and accumulation in GC tumors. (a) E...
Additional file 4: Figure S3. The changes of peripheral T cell cohorts and PD-1 expression after tre...
BackgroundGastric cancer is still one of the most lethal tumor diseases in the world. Despite some i...
Figure S5. Tumor-infiltrating and tumor-conditioned mast cells suppress T cell immunity through PD-L...
Figure S3. Tumor-derived factor TNF-α induces mast cells to express PD-L1. (a) Expression of 2B4, gl...
BackgroundGastric cancer is still one of the most lethal tumor diseases in the world. Despite some i...
Supplemental Figure S1. (A) Alternate gating strategy for identifying γδ T cells in KitV558Δ/+ tumor...
Figure S2. TIM-1+Breg cells are a regulatory B cell subset that promoted HCC progression by impairin...
Table S2. Clinical characteristics of 114 patients with gastric cancer. (DOCX 19 kb
Additional file 1: Figure S1. Coexistence of CD169, CD204 and CD68 in intra-tumor (IT) of HCC and GC...
Figure S4. Tumor-derived TNF-α activates NF-κB pathway to induce PD-L1 expression on mast cells. (a)...
BackgroundGastric cancer is still one of the most lethal tumor diseases in the world. Despite some i...
Additional file 3: Figure S3. Effects of PD-1+ and Tim-3+ inhibition on IFN-Îł induction. (A) Flow c...
Figure S1. Fluorescence-activated cell sorting of CD133 in gastric cancer cell lines. CD133- cells w...
Table S1. Clinicopathological features of diffuse-type GC patients whose cancers were used to establ...
Figure S2. CXCL12-CXCR4 chemotaxis mediates mast cell migration and accumulation in GC tumors. (a) E...
Additional file 4: Figure S3. The changes of peripheral T cell cohorts and PD-1 expression after tre...
BackgroundGastric cancer is still one of the most lethal tumor diseases in the world. Despite some i...
Figure S5. Tumor-infiltrating and tumor-conditioned mast cells suppress T cell immunity through PD-L...
Figure S3. Tumor-derived factor TNF-α induces mast cells to express PD-L1. (a) Expression of 2B4, gl...
BackgroundGastric cancer is still one of the most lethal tumor diseases in the world. Despite some i...
Supplemental Figure S1. (A) Alternate gating strategy for identifying γδ T cells in KitV558Δ/+ tumor...
Figure S2. TIM-1+Breg cells are a regulatory B cell subset that promoted HCC progression by impairin...
Table S2. Clinical characteristics of 114 patients with gastric cancer. (DOCX 19 kb
Additional file 1: Figure S1. Coexistence of CD169, CD204 and CD68 in intra-tumor (IT) of HCC and GC...
Figure S4. Tumor-derived TNF-α activates NF-κB pathway to induce PD-L1 expression on mast cells. (a)...
BackgroundGastric cancer is still one of the most lethal tumor diseases in the world. Despite some i...